On the filings, Align (ALGN) is the stronger stock right now — higher on our blended fundamentals-plus-verdict read, and we currently rate it SELL.
Flat revenue, eroding margins and 4 straight years of falling ortho starts don't justify its multiple.
Cheap at its multiple, but five straight years of falling revenue, serial impairments and rising debt make XRAY a value trap.
| Metric | ALGN | XRAY |
|---|---|---|
| Fundamentals score | 66 | 43 |
| Revenue growth (YoY) | +0.9% | -3.0% |
| Net income growth (YoY) | -2.6% | +34.3% |
| Net margin | 10.2% | -16.3% |
| Return on equity | 10.1% | -44.7% |
| ROIC (est.) | 10.6% | -9.3% |
| Liabilities / Equity | 0.54 | 3.05 |
| Piotroski F-score | 6 / 9 | 5 / 9 |
Bold green = the stronger figure. All rows derive from SEC XBRL filings — no market-price data on this page.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 9, 2026, 9:32 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 12:24 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.